<DOC>
	<DOCNO>NCT00892684</DOCNO>
	<brief_summary>The incidence allergic disease increase relation allergy dietary fatty acid propose . Modulation maternal immune function pregnancy may impact future clinical outcome child . The aim study determine effect omega ( ω ) - 3 long-chain polyunsaturated fatty acid ( LCPUFA ) supplementation pregnancy lactation development allergic disease ( i.e. , allergic eczema ) child 2 year age . Pregnant woman allergic disease immediate family supplement daily 2.7 g ω-3 LCPUFA ( n=70 ) 2.8 g soybean-oil placebo ( n=75 ) gestational week ( gw ) 25 third month breastfeeding . Skin prick test , detection circulate specific IgE antibody clinical examination infant perform 3 , 6 , 12 24 month age . The mother child monitor regard immune modulatory effect entire study period .</brief_summary>
	<brief_title>Does Omega-3 Fatty Acid Supplementation Pregnancy During Lactation Protect Child From Allergic Disease ?</brief_title>
	<detailed_description />
	<criteria>Pregnant woman , 25 week gestation , allergic symptom ( rhinitis , conjunctivitis , eczema , asthma food allergy ) father old sibling Soy allergy Fish allergy Treatment anticoagulation Commercial omega3 supplementation</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Randomized</keyword>
	<keyword>Placebo control</keyword>
	<keyword>Double blind</keyword>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Childhood allergy</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Eicosanoids</keyword>
	<keyword>Polyunsaturated fatty acid</keyword>
</DOC>